Advertisement

Mobile Banner
Mobile Banner
Mobile Banner
Loading...

Haleon plc

HLNNYSE
Healthcare
Drug Manufacturers - Specialty & Generic
$11.11
$-0.16(-1.42%)
U.S. Market opens in 17h 9m

Haleon plc Fundamental Analysis

Haleon plc (HLN) shows moderate financial fundamentals with a PE ratio of 15.65, profit margin of 14.57%, and ROE of 15.01%. The company generates $16.5B in annual revenue with weak year-over-year growth of -0.61%.

Key Strengths

Operating Margin21.55%

Areas of Concern

Cash Position1.35%
PEG Ratio5.28
Current Ratio0.87
We analyze HLN's fundamental strength across five key dimensions.

The stock receives a Fundamental Health Score of 44.7/100 based on profitability, valuation, growth, and balance sheet metrics. The D grade reflects weak fundamentals and significant financial concerns.

Fundamental Health Score

D
44.7/100

We analyze HLN's fundamental strength across five key dimensions:

Efficiency Score

Weak

HLN struggles to generate sufficient returns from assets.

ROA > 10%
7.57%

Valuation Score

Moderate

HLN shows balanced valuation metrics.

PE < 25
15.65
PEG Ratio < 2
5.28

Growth Score

Moderate

HLN shows steady but slowing expansion.

Revenue Growth > 5%
-0.61%
EPS Growth > 10%
45.45%

Financial Health Score

Moderate

HLN shows balanced financial health with some risks.

Debt/Equity < 1
0.53
Current Ratio > 1
0.87

Profitability Score

Moderate

HLN maintains healthy but balanced margins.

ROE > 15%
15.01%
Net Margin ≥ 15%
14.57%
Positive Free Cash Flow
Yes

Key Financial Metrics

Is HLN Expensive or Cheap?

P/E Ratio

HLN trades at 15.65 times earnings. This indicates a fair valuation.

15.65

PEG Ratio

When adjusting for growth, HLN's PEG of 5.28 indicates potential overvaluation.

5.28

Price to Book

The market values Haleon plc at 2.37 times its book value. This may indicate undervaluation.

2.37

EV/EBITDA

Enterprise value stands at 7.37 times EBITDA. This is generally considered low.

7.37

How Well Does HLN Make Money?

Net Profit Margin

For every $100 in sales, Haleon plc keeps $14.57 as profit after all expenses.

14.57%

Operating Margin

Core operations generate 21.55 in profit for every $100 in revenue, before interest and taxes.

21.55%

ROE

Management delivers $15.01 in profit for every $100 of shareholder equity.

15.01%

ROA

Haleon plc generates $7.57 in profit for every $100 in assets, demonstrating efficient asset deployment.

7.57%

Following the Money - Real Cash Generation

Operating Cash Flow

Haleon plc generates limited operating cash flow of $1.12B, signaling weaker underlying cash strength.

$1.12B

Free Cash Flow

Haleon plc produces free cash flow of $1.03B, offering steady but limited capital for shareholder returns and expansion.

$1.03B

FCF Per Share

Each share generates $0.23 in free cash annually.

$0.23

FCF Yield

HLN converts 2.75% of its market value into free cash.

2.75%

Financial Ratios Analysis

Valuation Ratios

P/E Ratio

Price to earnings ratio

15.65

vs 25 benchmark

PEG Ratio

Price/earnings to growth ratio

5.28

vs 25 benchmark

P/B Ratio

Price to book value ratio

2.37

vs 25 benchmark

P/S Ratio

Price to sales ratio

2.27

vs 25 benchmark

Financial Health

Debt/Equity

Total debt to shareholders' equity

0.53

vs 25 benchmark

Current Ratio

Current assets to current liabilities

0.87

vs 25 benchmark

Efficiency Ratios

ROE

Return on equity percentage

0.15

vs 25 benchmark

ROA

Return on assets percentage

0.08

vs 25 benchmark

ROCE

Return on capital employed

0.13

vs 25 benchmark

How HLN Stacks Against Its Sector Peers

MetricHLN ValueSector AveragePerformance
P/E Ratio15.6529.43 Better (Cheaper)
ROE15.01%800.00% Weak
Net Margin14.57%-20145.00% (disorted) Strong
Debt/Equity0.530.30 Weak (High Leverage)
Current Ratio0.874.64 Weak Liquidity
ROA7.57%-17936.00% (disorted) Weak

HLN outperforms its industry in 2 out of 6 key metrics, particularly excelling in Net Margin, but lagging in ROE.

Historical Growth Performance

5-Year Growth Trajectory

This section reviews Haleon plc's 5-year compound annual growth rate (CAGR) and compares its performance against the typical investment style of its industry.

Revenue CAGR

34.03%

Industry Style: Defensive, Growth, Innovation

High Growth

EPS CAGR

122.76%

Industry Style: Defensive, Growth, Innovation

High Growth

FCF CAGR

196.21%

Industry Style: Defensive, Growth, Innovation

High Growth

Fundamental Analysis FAQ